Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Focused Fund median (28 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Franklin India Focused Equity Fund |
|---|---|
| 01 Jan 2013 | ₹100.00 |
| 20 Feb 2014 | ₹106.48 |
| 11 Apr 2015 | ₹214.78 |
| 30 May 2016 | ₹204.00 |
| 19 Jul 2017 | ₹269.16 |
| 07 Sep 2018 | ₹290.78 |
| 27 Oct 2019 | ₹292.63 |
| 14 Dec 2020 | ₹342.63 |
| 02 Feb 2022 | ₹512.12 |
| 24 Mar 2023 | ₹499.62 |
| 12 May 2024 | ₹726.94 |
| 01 Jul 2025 | ₹837.47 |
| 20 Aug 2026 | ₹799.63 |
| Metric | Franklin Templeton · Direct NAV ₹116.89 Very High risk ★★★☆☆ | Category median Focused Fund · 28 funds |
|---|---|---|
| -5.35% | +5.84% | |
| +10.60% | +15.09% | |
| +12.37% | +13.35% | |
| +13.47% | +13.62% | |
| +16.48% | +15.49% | |
| +9.20% | — | |
| +17.40% | +16.73% | |
| +16.69% | +16.52% | |
| +16.92% | +16.05% | |
| Risk | ||
| 13.10% | 14.55% | |
| 0.31 | 0.57 | |
| 0.43 | 0.79 | |
| -37.69% | -34.05% | |
| Nifty 500 | — | |
| -0.86% | +3.16% | |
| 0.86 | 0.94 | |
| 90.8% | 104.9% | |
| 94.2% | 89.6% | |
| 1.17% | 1.06% | |
| ₹11,363Cr | ₹2,441Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 6% | 32% | |
| Ajay Argal · 4.8y | — | |
| 01 Jan 2013 | — | |
| 29 | — | |
| 58.6% | — | |
| 4.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.